Calcific Uremic Arteriolopathy: A Case Series and Review from an Inner-City Tertiary University Center in End-Stage Renal Disease Patients on Renal Replacement Therapy

Background and Objectives. Calcific uremic arteriolopathy (CUA) is a rare complication seen, especially in patients undergoing renal replacement therapy (RRT) with high morbidity and mortality. CUA treatment remains challenging. The study evaluated CUA's multifaceted treatment efficacy. Materia...

Full description

Saved in:
Bibliographic Details
Main Authors: Mohamed Omer, Zeenat Yousuf Bhat, Nanette Fonte, Nashat Imran, James Sondheimer, Yahya Osman‐Malik
Format: Article
Language:English
Published: Wiley 2021-01-01
Series:International Journal of Nephrology
Online Access:http://dx.doi.org/10.1155/2021/6661042
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832566023030571008
author Mohamed Omer
Zeenat Yousuf Bhat
Nanette Fonte
Nashat Imran
James Sondheimer
Yahya Osman‐Malik
author_facet Mohamed Omer
Zeenat Yousuf Bhat
Nanette Fonte
Nashat Imran
James Sondheimer
Yahya Osman‐Malik
author_sort Mohamed Omer
collection DOAJ
description Background and Objectives. Calcific uremic arteriolopathy (CUA) is a rare complication seen, especially in patients undergoing renal replacement therapy (RRT) with high morbidity and mortality. CUA treatment remains challenging. The study evaluated CUA's multifaceted treatment efficacy. Materials and Methods. 24 patients with CUA and on RRT were evaluated at Detroit Medical Center from 2007 to 2016. Skin biopsy was used in almost all patients, along with the radiological and clinical findings. The patient’s clinical and paraclinical data were retrieved from the electronic medical records. The effect of treatment modalities and the underlying hyperparathyroidism management were compared to the clinical outcomes using appropriate statistical tests. Results. Twenty-one patients were on hemodialysis, two patients received renal transplants, and one patient was on peritoneal dialysis. Diabetes mellitus was the most prevalent cause of ESRD. The parathyroid hormone level (PTH) was elevated in 22 patients. Fifteen patients were diagnosed 2 weeks or more prior to skin lesion onset. Twenty-two and thirteen patients received sodium thiosulphate and cinacalcet, respectively. Patients with lower PTH and the calcium-phosphate product levels had a relatively better outcome of CUA. Conclusions. A multifaceted approach may play a role in treating CUA. Referral to a nephrologist may aid in the early diagnosis and prompt management of CUA.
format Article
id doaj-art-cbe9bd4f504a4a8fb9052049a230e00e
institution Kabale University
issn 2090-214X
2090-2158
language English
publishDate 2021-01-01
publisher Wiley
record_format Article
series International Journal of Nephrology
spelling doaj-art-cbe9bd4f504a4a8fb9052049a230e00e2025-02-03T01:05:28ZengWileyInternational Journal of Nephrology2090-214X2090-21582021-01-01202110.1155/2021/66610426661042Calcific Uremic Arteriolopathy: A Case Series and Review from an Inner-City Tertiary University Center in End-Stage Renal Disease Patients on Renal Replacement TherapyMohamed Omer0Zeenat Yousuf Bhat1Nanette Fonte2Nashat Imran3James Sondheimer4Yahya Osman‐Malik5Division of Infectious Diseases, Mayo Clinic, Jacksonville, Florida, USADivision of Nephrology and Hypertension, Wayne State University, Detroit Medical Center, Detroit, USAAntelope Valley Nephrology Medical Group, Lancaster, California, USADivision of Nephrology and Hypertension, Wayne State University, Detroit Medical Center, Detroit, USADivision of Nephrology and Hypertension, Wayne State University, Detroit Medical Center, Detroit, USADivision of Nephrology and Hypertension, Wayne State University, Detroit Medical Center, Detroit, USABackground and Objectives. Calcific uremic arteriolopathy (CUA) is a rare complication seen, especially in patients undergoing renal replacement therapy (RRT) with high morbidity and mortality. CUA treatment remains challenging. The study evaluated CUA's multifaceted treatment efficacy. Materials and Methods. 24 patients with CUA and on RRT were evaluated at Detroit Medical Center from 2007 to 2016. Skin biopsy was used in almost all patients, along with the radiological and clinical findings. The patient’s clinical and paraclinical data were retrieved from the electronic medical records. The effect of treatment modalities and the underlying hyperparathyroidism management were compared to the clinical outcomes using appropriate statistical tests. Results. Twenty-one patients were on hemodialysis, two patients received renal transplants, and one patient was on peritoneal dialysis. Diabetes mellitus was the most prevalent cause of ESRD. The parathyroid hormone level (PTH) was elevated in 22 patients. Fifteen patients were diagnosed 2 weeks or more prior to skin lesion onset. Twenty-two and thirteen patients received sodium thiosulphate and cinacalcet, respectively. Patients with lower PTH and the calcium-phosphate product levels had a relatively better outcome of CUA. Conclusions. A multifaceted approach may play a role in treating CUA. Referral to a nephrologist may aid in the early diagnosis and prompt management of CUA.http://dx.doi.org/10.1155/2021/6661042
spellingShingle Mohamed Omer
Zeenat Yousuf Bhat
Nanette Fonte
Nashat Imran
James Sondheimer
Yahya Osman‐Malik
Calcific Uremic Arteriolopathy: A Case Series and Review from an Inner-City Tertiary University Center in End-Stage Renal Disease Patients on Renal Replacement Therapy
International Journal of Nephrology
title Calcific Uremic Arteriolopathy: A Case Series and Review from an Inner-City Tertiary University Center in End-Stage Renal Disease Patients on Renal Replacement Therapy
title_full Calcific Uremic Arteriolopathy: A Case Series and Review from an Inner-City Tertiary University Center in End-Stage Renal Disease Patients on Renal Replacement Therapy
title_fullStr Calcific Uremic Arteriolopathy: A Case Series and Review from an Inner-City Tertiary University Center in End-Stage Renal Disease Patients on Renal Replacement Therapy
title_full_unstemmed Calcific Uremic Arteriolopathy: A Case Series and Review from an Inner-City Tertiary University Center in End-Stage Renal Disease Patients on Renal Replacement Therapy
title_short Calcific Uremic Arteriolopathy: A Case Series and Review from an Inner-City Tertiary University Center in End-Stage Renal Disease Patients on Renal Replacement Therapy
title_sort calcific uremic arteriolopathy a case series and review from an inner city tertiary university center in end stage renal disease patients on renal replacement therapy
url http://dx.doi.org/10.1155/2021/6661042
work_keys_str_mv AT mohamedomer calcificuremicarteriolopathyacaseseriesandreviewfromaninnercitytertiaryuniversitycenterinendstagerenaldiseasepatientsonrenalreplacementtherapy
AT zeenatyousufbhat calcificuremicarteriolopathyacaseseriesandreviewfromaninnercitytertiaryuniversitycenterinendstagerenaldiseasepatientsonrenalreplacementtherapy
AT nanettefonte calcificuremicarteriolopathyacaseseriesandreviewfromaninnercitytertiaryuniversitycenterinendstagerenaldiseasepatientsonrenalreplacementtherapy
AT nashatimran calcificuremicarteriolopathyacaseseriesandreviewfromaninnercitytertiaryuniversitycenterinendstagerenaldiseasepatientsonrenalreplacementtherapy
AT jamessondheimer calcificuremicarteriolopathyacaseseriesandreviewfromaninnercitytertiaryuniversitycenterinendstagerenaldiseasepatientsonrenalreplacementtherapy
AT yahyaosmanmalik calcificuremicarteriolopathyacaseseriesandreviewfromaninnercitytertiaryuniversitycenterinendstagerenaldiseasepatientsonrenalreplacementtherapy